CN105878739A - 一种具有控制痛风发作功能的保健食品及其生产方法 - Google Patents
一种具有控制痛风发作功能的保健食品及其生产方法 Download PDFInfo
- Publication number
- CN105878739A CN105878739A CN201610446447.0A CN201610446447A CN105878739A CN 105878739 A CN105878739 A CN 105878739A CN 201610446447 A CN201610446447 A CN 201610446447A CN 105878739 A CN105878739 A CN 105878739A
- Authority
- CN
- China
- Prior art keywords
- parts
- health
- gout
- raw material
- care food
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 201000005569 Gout Diseases 0.000 title claims abstract description 38
- 238000002360 preparation method Methods 0.000 title claims 2
- 235000013305 food Nutrition 0.000 title abstract description 14
- 239000002994 raw material Substances 0.000 claims abstract description 26
- 241000208340 Araliaceae Species 0.000 claims abstract description 10
- 240000000759 Lepidium meyenii Species 0.000 claims abstract description 10
- 235000000421 Lepidium meyenii Nutrition 0.000 claims abstract description 10
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 10
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 10
- 235000008434 ginseng Nutrition 0.000 claims abstract description 10
- 210000001320 hippocampus Anatomy 0.000 claims abstract description 10
- 238000001035 drying Methods 0.000 claims abstract description 8
- 238000004806 packaging method and process Methods 0.000 claims abstract description 4
- 235000013402 health food Nutrition 0.000 claims description 24
- 235000012902 lepidium meyenii Nutrition 0.000 claims description 9
- 239000000843 powder Substances 0.000 claims description 9
- 238000000034 method Methods 0.000 claims description 7
- 239000006187 pill Substances 0.000 claims description 6
- 239000002671 adjuvant Substances 0.000 claims description 5
- 235000013312 flour Nutrition 0.000 claims description 3
- 239000012535 impurity Substances 0.000 claims description 3
- 239000012567 medical material Substances 0.000 claims description 3
- 238000012856 packing Methods 0.000 claims description 3
- 230000008569 process Effects 0.000 claims description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 6
- 235000005911 diet Nutrition 0.000 abstract description 2
- 238000000227 grinding Methods 0.000 abstract description 2
- 239000004615 ingredient Substances 0.000 abstract description 2
- 241001478428 Syngnathus Species 0.000 abstract 1
- 230000000378 dietary effect Effects 0.000 abstract 1
- 238000002791 soaking Methods 0.000 abstract 1
- 230000006870 function Effects 0.000 description 21
- 238000004519 manufacturing process Methods 0.000 description 7
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 6
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 6
- 229940116269 uric acid Drugs 0.000 description 6
- 210000003734 kidney Anatomy 0.000 description 5
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 4
- 208000002193 Pain Diseases 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 230000001154 acute effect Effects 0.000 description 2
- 230000006978 adaptation Effects 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 230000029142 excretion Effects 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 208000006820 Arthralgia Diseases 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 201000001431 Hyperuricemia Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 235000013405 beer Nutrition 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000019771 cognition Effects 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000027950 fever generation Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- NAFSTSRULRIERK-UHFFFAOYSA-M monosodium urate Chemical class [Na+].N1C([O-])=NC(=O)C2=C1NC(=O)N2 NAFSTSRULRIERK-UHFFFAOYSA-M 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 230000004768 organ dysfunction Effects 0.000 description 1
- 201000008482 osteoarthritis Diseases 0.000 description 1
- 235000014102 seafood Nutrition 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 150000007968 uric acids Chemical class 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 230000003313 weakening effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8969—Polygonatum (Solomon's seal)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/60—Fish, e.g. seahorses; Fish eggs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/20—Natural extracts
- A23V2250/204—Animal extracts
- A23V2250/2042—Marine animal, fish extracts
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/20—Natural extracts
- A23V2250/21—Plant extracts
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2300/00—Processes
- A23V2300/14—Extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Marine Sciences & Fisheries (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
本发明属于保健食品技术领域，具体涉及一种具有控制痛风发作功能的保健食品，所述一种具有控制痛风发作功能的保健食品，包括下列重量配比的原料制成：黄精15‑55份、人参10‑32份、玛卡9‑22份、枸杞子3‑15份、海马7‑18份、海龙2‑10份。上述原料通过浸泡、干燥、制粉加入适量辅料压片包装等步骤而制成，本发明的保健食品具有控制、缓解痛风发作的功能。可以使有痛风病的人群，在不用忌口的情况下，控制自己的痛风病不再发作。
Description
技术领域
本发明涉及一种具有控制痛风发作功能的保健食品及其生产方法，属保健食品技术领域。
背景技术
痛风是由单钠尿酸盐(MSU)沉积所致的晶体相关性关节病,与嘌呤代谢紊乱和(或)尿酸排泄减少所致的高尿酸血症直接相关,特指急性特征性关节炎和慢性痛风石疾病。随着经济发展和生活方式改变,其患病率逐渐上升。发作期:常在夜间发作的急性单关节或多关节疼痛,呈剧痛,体征类似于急性感染,有肿胀,局部发热,红及明显触痛等,目前控制痛风发作的主要手段是：要养成一个良好的生活习惯,要忌口，饮食上要少食动物内脏、海鲜、鱼类等嘌呤含量高的食物，不能饮酒特别是啤酒。现有技术还没有既能不用忌口又能控制痛风发作的方法及产品。
发明内容
本发明提供一种具有控制痛风发作功能的保健食品及其生产方法。
为实现以上目的，本发明所采用的技术方案：一种具有控制痛风发作功能的保健食品，其原料重量配比为
：黄精 15-55份、人参 10-32份、玛卡9-22份、枸杞子3 -15份、海马7 -18份、海龙 2-10份。
所述一种具有控制痛风发作功能的保健食品，优选地包括下列重量配比的原料制成
：黄精 19-40份、人参 15-25份、玛卡7-21份、枸杞子6 -13份、海马8 -16份、海龙 3-10份。
所述一种具有控制痛风发作功能的保健食品进一步优选地包括下列重量配比的原料制成
：黄精 26-33份、人参 18-24份、玛卡9-20份、枸杞子8 -12份、海马9 -14份、海龙 4-8份。
所述一种具有控制痛风发作功能的保健食品，可采用下列步骤的生产方法制备
：
1) 称取重量配比的原料 ；
2)将上述原料采用 20℃ -30℃的纯净水浸泡 1-3 小时，除去药材表面的杂质。
3)干燥：进入干燥机3-5小时，温度控制30℃ -45℃
4)制粉：使用专用磨粉机，采用细胞级超微粉碎把上述原料粉碎到≤48μm。
5)干燥：把制成的原料粉烘干12小时，温度控制35℃ -45℃。
6)压片包装：烘干后的原料粉加入适量的辅料进入压片机压制成药丸，之后对药丸进行包衣，用泡罩板包装，装入外包装盒。
本发明提供一种具有控制痛风发作的保健食品，具有良好的增强肾脏排泄功能，使机体适应内外环境的改变，减轻因尿酸排出功能降低致病因素对机体的损害，提示机体的抗病能力，可不用忌口又能控制、缓解痛风的发作。
本发明提供的一种具有控制痛风发作功能的保健食品的生产方法，没有天然植物药理有效成分的损失，工艺简单，所需设备少，适合工业化生产，市场前景好。
具体实施方式：
下面通过具体实施例对本案发明的技术方案进行详细说明：
实施例1：
一种具有控制痛风发作功能的保健食品，其原料重量配比为：黄精 15-55份、人参 10-32份、玛卡9-22份、枸杞子3 -15份、海马7
-18份、海龙 2-10份。
实施例2：
一种具有控制痛风发作功能的保健食品，其原料重量配比为：黄精 19-40份、人参 15-25份、玛卡7-21份、枸杞子6 -13份、海马8
-16份、海龙 3-10份。
实施例3：
一种具有控制痛风发作功能的保健食品，其原料重量配比为：黄精 26-33份、人参 18-24份、玛卡9-20份、枸杞子8 -12份、海马9
-14份、海龙 4-8份。
可以理解，实施例1-3所述的一种具有控制痛风发作功能的保健食品，还包括适量辅料，所述辅料符合保健食品法规要求。
上述所述份为ɡ,Kɡ,吨等重量单位。
所述一种具有控制痛风发作功能的保健食品，其配方的设计是是依据中医对痛风病症的认知所设计。中医认为，痛风病发作主在于肝肾亏损证，肾脏和其他器官功能的减弱造成的。人体对营养进行消化吸收，把酸化的残渣排到体液和血液里，这就是我们所说的尿酸。体内2/3 的尿酸由肾脏排出体外，1/3 由大肠排出。这个尿酸正常由我们的肾脏过滤后随着尿液排出去，但是我内脏功能的下降，和一些药物对肾功能的影响，肾能过滤的就少了，这样积少成多，身体内的尿酸增多排不出去，就形成了尿酸盐结晶。而这个结晶随着血液走到肢体末端循环就堵住了，中医讲“不通则痛”，结晶越大越痛、剧痛，然后就是发炎。而本发明所提供的上述保健食品，具有具有良好的增强肾脏排泄功能，使机体适应内外环境的改变，减轻因尿酸排出功能降低致病因素对机体的损害，提示机体的抗病能力，可不用忌口又能控制、缓解痛风的发作。
所述一种具有控制痛风发作功能的保健食品，可采用下列步骤的生产方法制备：
1. 称取重量配比的原料 ；
2.将上述原料采用 20℃ -30℃的纯净水浸泡 1-3 小时，除去药材表面的杂质；
3.干燥：进入干燥机3-5小时，温度控制30℃ -45℃；
4.制粉：使用专用磨粉机，采用细胞级超微粉碎把上述原料粉碎到≤48μm（48μm≒300目）；
5.干燥：把制成的原料粉烘干12小时，温度控制35℃ -45℃；
6.压片包装：烘干后的原料粉加入适量的辅料进入压片机压制成药丸，之后对药丸进行包衣，用泡罩板包装，装入外包装盒，完成整个工序。
所述原料通过高精细研磨干燥，加入适量保健食品法规允许使用的辅料，制备成片剂、胶囊剂、颗粒剂等剂型。
所述项细胞级高精细研磨技术即现今中医药领域的超微粉碎技术。
所述一种具有控制痛风发作功能的保健食品，其服量推荐为，前15日，每日一次，之后每周一次，片剂和胶囊剂为7ɡ/次，、颗粒剂为7ɡ/次。
本发明提供的一种具有控制痛风发作功能的保健食品可不用忌口又能控制、缓解痛风的发作。
Claims (4)
1.一种具有控制痛风发作的保健食品，其特征在于：原料重量配比为：黄精
15-55份、人参 10-32份、玛卡9-22份、枸杞子3 -15份、海马7 -18份、海龙 2-10份。
2.根据权利要求1所述一种具有控制痛风发作的保健食品，其特征在于：原料重量配比为：黄精
19-40份、人参 15-25份、玛卡7-21份、枸杞子6 -13份、海马8 -16份、海龙 3-10份。
3.根据权利要求1所述一种具有控制痛风发作的保健食品，其特征在于：原料重量配比为：黄精
26-33份、人参 18-24份、玛卡9-20份、枸杞子8 -12份、海马9 -14份、海龙 4-8份。
4.根据权利要求1-3任一所述具有控制、缓解痛风发作功能的保健食品，其特征在于：制备方法包括一下步骤：
1） 称取重量配比的原料 ；
2）将上述原料采用 20℃ -30℃的纯净水浸泡 1-3 小时，除去药材表面的杂质；
3）干燥：进入干燥机3-5小时，温度控制30℃ -45℃；
4）制粉：使用专用磨粉机，采用细胞级超微粉碎把上述原料粉碎到≤48μm；
5）干燥：把制成的原料粉烘干12小时，温度控制35℃ -45℃；
6）压片包装：烘干后的原料粉加入适量的辅料进入压片机压制成药丸，之后对药丸进行包衣，用泡罩板包装，装入外包装盒。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610446447.0A CN105878739A (zh) | 2016-06-21 | 2016-06-21 | 一种具有控制痛风发作功能的保健食品及其生产方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610446447.0A CN105878739A (zh) | 2016-06-21 | 2016-06-21 | 一种具有控制痛风发作功能的保健食品及其生产方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105878739A true CN105878739A (zh) | 2016-08-24 |
Family
ID=56729895
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610446447.0A Pending CN105878739A (zh) | 2016-06-21 | 2016-06-21 | 一种具有控制痛风发作功能的保健食品及其生产方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105878739A (zh) |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103520179A (zh) * | 2009-12-21 | 2014-01-22 | 狮王株式会社 | 高血脂症改善剂、贫血改善组合物、尿酸值降低组合物以及饮料食品 |
| CN104479965A (zh) * | 2014-11-21 | 2015-04-01 | 张国平 | 一种黄精保健酒 |
| CN105199927A (zh) * | 2015-09-28 | 2015-12-30 | 楚雄州百草岭药业发展有限公司 | 一种玛咖酒及其制备方法 |
-
2016
- 2016-06-21 CN CN201610446447.0A patent/CN105878739A/zh active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103520179A (zh) * | 2009-12-21 | 2014-01-22 | 狮王株式会社 | 高血脂症改善剂、贫血改善组合物、尿酸值降低组合物以及饮料食品 |
| CN104479965A (zh) * | 2014-11-21 | 2015-04-01 | 张国平 | 一种黄精保健酒 |
| CN105199927A (zh) * | 2015-09-28 | 2015-12-30 | 楚雄州百草岭药业发展有限公司 | 一种玛咖酒及其制备方法 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN105192025A (zh) | 一种健脾和胃营养饼干及其制备方法 | |
| CN101130724A (zh) | 对肿瘤有辅助抑制作用的保健啤酒及其制备方法 | |
| CN102363024A (zh) | 一种治疗胃虚寒胃痛的中药制剂及制备方法 | |
| CN105878739A (zh) | 一种具有控制痛风发作功能的保健食品及其生产方法 | |
| CN102524473B (zh) | 一种无辅料型开奶茶及其制备方法 | |
| CN102743547A (zh) | 具有预防肥胖效果的减肥组合物及减肥液 | |
| CN107683923A (zh) | 一种润肠通便植物袋泡茶及其制备方法 | |
| CN103392982B (zh) | 排毒养颜奶粉 | |
| CN102755393A (zh) | 一种治疗肝病的药剂及其制备方法 | |
| CN103169900B (zh) | 一种用于治疗痛风的中药制剂 | |
| CN105961678A (zh) | 一种健胃消食保健茶及其制作方法 | |
| CN102150841A (zh) | 一种具有增强免疫力功能的保健冲剂及其制备方法 | |
| CN105768080A (zh) | 用富硒梅花鹿血原浆液制成的发酵食品及其制备方法 | |
| CN101485464B (zh) | 益肠中药添加剂 | |
| CN108125113A (zh) | 一种润肠通便改善便秘的保健食品及其制备方法 | |
| CN103127404A (zh) | 神经瘫痪康复酒 | |
| CN103250970A (zh) | 一种含党参的保健茶米粥及其制作方法 | |
| CN107929413A (zh) | 一种抗疲劳的中药组合物及其应用和制备方法 | |
| CN107183657A (zh) | 一种适合小孩食用的专用食用盐及其制备方法 | |
| CN101828633B (zh) | 中药家禽用饲料 | |
| CN101664140A (zh) | 荠菜营养食品 | |
| CN106566752A (zh) | 一种黄精粮酒 | |
| CN101164595A (zh) | 一种治疗厌食症的中药 | |
| CN105145985A (zh) | 一种健脑的养生茶冲剂及其制备方法 | |
| CN104522824B (zh) | 灯笼果速溶补钙冲剂 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20160824 |